Brazilian Federal Court of Appeals for the 2nd Circuit renders a favorable decision reinforcing the illegality of the article 32 of Normative Instruction # 30/2013 regarding the deadline to divide patent applications
Brazilian Federal Court of Appeals for the 2nd Circuit renders a favorable decision reinforcing the illegality of the article 32 of Normative Instruction # 30/2013 regarding the deadline to divide patent applications
Brazilian Ministry of Finance releases the Regulatory Impact Analysis (RIA) Report, recommending repealing CMED's Ordinance #2/2004 and the release of guidelines for transparency in the pricing process
Brazilian Federal Court of Appeals for the 2nd Circuit grants appeals, indicating that patent applications can be divided up to the end of the appellate level at the BRPTO
Brazilian Antitrust Authority dismisses investigation into alleged “term extension” of pharmaceutical-related patents, indicating position in favor of patent holders
The BRPTO released the final version of Technical Note BRPTO/CPAPD #01/2023 on the examination of transgenic plants inventions – particularly, elite events
Brazilian Legislative Power maintains President Bolsonaro’s veto to anti-patent legislation establishing that patent owners must provide information for compulsory licensing work of a patent (gunpoint tech transfer)
La décision provisoire de la Cour suprême interdit le mécanisme de 10 ans après délivrance pour les nouveaux brevets couvrant les produits pharmaceutiques et les dispositifs à usage médical.
%20ter%C3%A1%20quinta%20vara%20federal%20-%20POST.png)
%20reaches%20the%20limit%20of%20PPH%20requests%20in%202023%20-%20POST.png)
%20reaches%20the%20limit%20for%20PPH%20PCT%20requests%20in%202023%20-%20POST.jpg)
%20reaches%20the%20limit%20of%20PPH%20applications%20in%202022%20-%20POST.jpg)
